23 May 2019

TAVI Stable CAD

Controversies and future perspectives of antithrombotic therapy in atrial fibrillation patients undergoing coronary and valvular transcatheter interventions

Sponsored by Daiichi Sankyo

Chairpersons: D. Capodanno, H. Möllmann

Panellists: R. Moreno, P. Vranckx

SHOW MORE

Summary

Consult this session to learn about the updated perspective on the bleeding definition in interventional cardiology, and antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI or TAVI.

Learning Objectives

To discuss an updated perspective on the bleeding definition in interventional cardiology
To learn about antithrombotic treatment regimens in atrial fibrillation patients undergoing PCI
To learn about antithrombotic treatment regimens in atrial fibrillation patients undergoing TAVI

Presentations available when logged in:

Bleeding definitions in pharmaceutical and medical device studies – quest for alignment
Stroke prevention in AF patients post PCI – how to best combine antiplatelet and anticoagulation therapies
Prevention of embolic events post TAVI in AF patients – are antiplatelet agents needed?
Session evaluation and key learnings

Log in or create account for free

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…